These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18768675)

  • 1. Impact of white-coat hypertension on microvascular complications in type 2 diabetes.
    Kramer CK; Leitão CB; Canani LH; Gross JL
    Diabetes Care; 2008 Dec; 31(12):2233-7. PubMed ID: 18768675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White coat hypertension in type 1 diabetic patients without nephropathy.
    Flores L; Recasens M; Gomis R; Esmatjes E
    Am J Hypertens; 2000 May; 13(5 Pt 1):560-3. PubMed ID: 10826411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential follow-up clinic and ambulatory blood pressure evaluation in a low risk population of white-coat hypertensive patients and in normotensives.
    Polónia JJ; Gama GM; Silva JA; Amaral C; Martins LR; Bertoquini SE
    Blood Press Monit; 2005 Apr; 10(2):57-64. PubMed ID: 15812251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Masked hypertension, urinary albumin excretion rate, and echocardiographic parameters in putatively normotensive type 2 diabetic patients.
    Leitão CB; Canani LH; Kramer CK; Boza JC; Pinotti AF; Gross JL
    Diabetes Care; 2007 May; 30(5):1255-60. PubMed ID: 17303786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Predictive factors of hypertension in patients with diagnostic doubts of persistent hypertension].
    Mediavilla García JD; Sabio JM; Carrillo Alascio PL; Fernández Torres C; Aliaga Martínez L; Jiménez-Alonso J
    Med Clin (Barc); 2002 Oct; 119(11):401-4. PubMed ID: 12381272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Is prevalence of the "white coat effect" correlated with a high risk of late diabetic complications in type 2 diabetic patients?].
    Mozdzan M; Ruxer J; Barański M; Roszczyk N; Markuszewski L
    Ann Acad Med Stetin; 2008; 54(1):65-9; discussion 69. PubMed ID: 19127812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of white coat hypertension in Chinese Han patients with type 2 diabetes mellitus.
    Zhou J; Liu C; Shan P; Zhou Y; Xu E; Ji Y
    Clin Exp Hypertens; 2014; 36(5):321-5. PubMed ID: 24047449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hypertension in suspected hypertensive patients in Rajavithi Hospital using ambulatory blood pressure monitoring.
    Pengkeaw P; Suwannakarn S
    J Med Assoc Thai; 2014 Nov; 97 Suppl 11():S25-30. PubMed ID: 25509692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White coat effect in treated and untreated patients with high office blood pressure. Relationship with pulse wave velocity and left ventricular mass index.
    Silveira A; Mesquita A; Maldonado J; Silva JA; Polónia J
    Rev Port Cardiol; 2002 May; 21(5):517-30. PubMed ID: 12174516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic criteria of white coat hypertension (WCH): consequences for the implications of WCH for target organs.
    Pose-Reino A; Rodríguez-Fernández M; López-Barreiro L; Coleman IC; Estévez-Nuñez JC; Méndez-Naya I
    Blood Press; 2002; 11(3):144-50. PubMed ID: 12126260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and clinical correlates of white coat hypertension in chronic kidney disease.
    Minutolo R; Borrelli S; Scigliano R; Bellizzi V; Chiodini P; Cianciaruso B; Nappi F; Zamboli P; Conte G; De Nicola L
    Nephrol Dial Transplant; 2007 Aug; 22(8):2217-23. PubMed ID: 17420167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of micro and macroangiopatic chronic complications and their risk factors in the care of out patients with type 2 diabetes mellitus].
    Scheffel RS; Bortolanza D; Weber CS; Costa LA; Canani LH; Santos KG; Crispim D; Roisenberg I; Lisbôa HR; Tres GS; Tschiedel B; Gross JL
    Rev Assoc Med Bras (1992); 2004; 50(3):263-7. PubMed ID: 15499476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular prognosis of sustained and white-coat hypertension in patients with type 2 diabetes mellitus.
    Eguchi K; Hoshide S; Ishikawa J; Ishikawa S; Pickering TG; Gerin W; Ogedegbe G; Schwartz JE; Shimada K; Kario K
    Blood Press Monit; 2008 Feb; 13(1):15-20. PubMed ID: 18199919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial distensibility in subjects with white-coat hypertension with and without diabetes or dyslipidaemia: comparison with normotensives and sustained hypertensives.
    Ribeiro L; Gama G; Santos A; Asmar R; Martins L; Polónia J
    Blood Press Monit; 2000 Feb; 5(1):11-7. PubMed ID: 10804446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperhomocysteinemia: an additional risk factor in white coat hypertension.
    Curgunlu A; Karter Y; Uzun H; Aydin S; Ertürk N; Vehid S; Simsek G; Kutlu A; Oztürk E; Erdine S
    Int Heart J; 2005 Mar; 46(2):245-54. PubMed ID: 15876808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White coat hypertension in NIDDM patients with and without incipient and overt diabetic nephropathy.
    Nielsen FS; Gaede P; Vedel P; Pedersen O; Parving HH
    Diabetes Care; 1997 May; 20(5):859-63. PubMed ID: 9135956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure means rather than nocturnal dipping pattern are related to complications in Type 2 diabetic patients.
    Leitão CB; Canani LH; Kramer CK; Moehlecke M; Pinto LC; Ricardo ED; Pinotti AF; Gross JL
    Diabet Med; 2008 Mar; 25(3):308-13. PubMed ID: 18201207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Task force IV: Clinical use of ambulatory blood pressure monitoring. Participants of the 1999 Consensus Conference on Ambulatory Blood Pressure Monitoring.
    Staessen JA; Beilin L; Parati G; Waeber B; White W
    Blood Press Monit; 1999 Dec; 4(6):319-31. PubMed ID: 10602536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between cardiovascular risk factors and white-coat hypertension diagnosed by home blood pressure recordings in a middle-aged population.
    Johansson MAK; Östgren CJ; Engvall J; Swahn E; Wijkman M; Nystrom FH
    J Hypertens; 2021 Oct; 39(10):2009-2014. PubMed ID: 33973957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
    Estacio RO; Jeffers BW; Gifford N; Schrier RW
    Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.